KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Global Medical REIT (GMRE) Shares Issued (2016 - 2022)

Historic Shares Issued for Global Medical REIT (GMRE) over the last 10 years, with Q4 2022 value amounting to -$83000.0.

  • Global Medical REIT's Shares Issued fell 10074.85% to -$83000.0 in Q4 2022 from the same period last year, while for Dec 2024 it was $1.7 million, marking a year-over-year change of. This contributed to the annual value of $10.9 million for FY2024, which is N/A changed from last year.
  • Per Global Medical REIT's latest filing, its Shares Issued stood at -$83000.0 for Q4 2022, which was down 10074.85% from $1.8 million recorded in Q2 2022.
  • Over the past 5 years, Global Medical REIT's Shares Issued peaked at $144.3 million during Q1 2021, and registered a low of -$83000.0 during Q4 2022.
  • Moreover, its 5-year median value for Shares Issued was $13.0 million (2020), whereas its average is $32.7 million.
  • Per our database at Business Quant, Global Medical REIT's Shares Issued surged by 43437.21% in 2019 and then tumbled by 10074.85% in 2022.
  • Over the past 5 years, Global Medical REIT's Shares Issued (Quarter) stood at $34.1 million in 2018, then surged by 171.86% to $92.7 million in 2019, then crashed by 83.87% to $15.0 million in 2020, then decreased by 25.83% to $11.1 million in 2021, then plummeted by 100.75% to -$83000.0 in 2022.
  • Its last three reported values are -$83000.0 in Q4 2022, $1.8 million for Q2 2022, and $8.2 million during Q1 2022.